Enanta制药公司预计2024年第四季度收入为1460万美元,低于预期的1790万美元;预计调整后每股收益为-1.36美元,低于预期的-1.16美元

财报速递
03 Dec 2024

Enanta制药公司预计2024年第四季度收入为1460万美元,低于预期的1790万美元;预计调整后每股收益为-1.36美元,低于预期的-1.16美元。



以上内容来自Benzinga Earnings专栏,原文如下:

Enanta Pharmaceuticals Sees Q4 2024 Revenue $14.6M Vs $17.9M Estimate; Sees Adj. EPS $-1.36 Vs $-1.16

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10